FDMT
4D Molecular Therapeutics, Inc.
Latest close $10.26 as of Aug 4, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 7 parsed filing(s) · 4 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| State Street CIK0000093751 | Mar 31, 2026 observed May 12, 2026 filed · 42d Initial Schedule 13G | Initial Schedule 13G | 2.7M | 12.00% | $9.31 | $10.34 | $10.26 |
| BlackRock CIK0002012383 | Sep 30, 2025 observed Oct 17, 2025 filed · 17d Schedule 13G amendment | Reported reduction | 3.1M -1.9M | 12.00% +1.30 pts | $10.26 | ||
| BlackRock CIK0002012383 | Nov 30, 2024 observed Dec 6, 2024 filed · 6d Schedule 13G amendment | Reported accumulation | 5.0M +96.2K | 10.70% +1.30 pts | $7.35 | $10.26 |